BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 9840937)

  • 1. Regulation of CAK kinase activity by p53.
    Schneider E; Montenarh M; Wagner P
    Oncogene; 1998 Nov; 17(21):2733-41. PubMed ID: 9840937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Cdk-activating kinase subunits with transcription factor TFIIH.
    Serizawa H; Mäkelä TP; Conaway JW; Conaway RC; Weinberg RA; Young RA
    Nature; 1995 Mar; 374(6519):280-2. PubMed ID: 7885450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner.
    Ko LJ; Shieh SY; Chen X; Jayaraman L; Tamai K; Taya Y; Prives C; Pan ZQ
    Mol Cell Biol; 1997 Dec; 17(12):7220-9. PubMed ID: 9372954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Cdk7/cyclin H/MAT1 the genuine cdk activating kinase in cycling Xenopus egg extracts?
    Fesquet D; Morin N; Doree M; Devault A
    Oncogene; 1997 Sep; 15(11):1303-7. PubMed ID: 9315098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C inhibits the CAK-CDK2 cyclin-dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts.
    Hamada K; Takuwa N; Zhou W; Kumada M; Takuwa Y
    Biochim Biophys Acta; 1996 Jan; 1310(1):149-56. PubMed ID: 9244189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells.
    Lawrie AM; Tito P; Hernandez H; Brown NR; Robinson CV; Endicott JA; Noble ME; Johnson LN
    Protein Expr Purif; 2001 Nov; 23(2):252-60. PubMed ID: 11676600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity.
    Nagahara H; Ezhevsky SA; Vocero-Akbani AM; Kaldis P; Solomon MJ; Dowdy SF
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14961-6. PubMed ID: 10611320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.
    Higashi H; Suzuki-Takahashi I; Saitoh S; Segawa K; Taya Y; Okuyama A; Nishimura S; Kitagawa M
    Eur J Biochem; 1996 Apr; 237(2):460-7. PubMed ID: 8647086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
    Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
    Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.
    Matsuoka M; Kato JY; Fisher RP; Morgan DO; Sherr CJ
    Mol Cell Biol; 1994 Nov; 14(11):7265-75. PubMed ID: 7935441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity.
    Nekhai S; Shukla RR; Kumar A
    J Virol; 1997 Oct; 71(10):7436-41. PubMed ID: 9311822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II.
    Watanabe Y; Fujimoto H; Watanabe T; Maekawa T; Masutani C; Hanaoka F; Ohkuma Y
    Genes Cells; 2000 May; 5(5):407-23. PubMed ID: 10886368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities.
    Kaldis P; Russo AA; Chou HS; Pavletich NP; Solomon MJ
    Mol Biol Cell; 1998 Sep; 9(9):2545-60. PubMed ID: 9725911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors.
    Inamoto S; Segil N; Pan ZQ; Kimura M; Roeder RG
    J Biol Chem; 1997 Nov; 272(47):29852-8. PubMed ID: 9368058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine.
    Kaldis P; Cheng A; Solomon MJ
    J Biol Chem; 2000 Oct; 275(42):32578-84. PubMed ID: 10931829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CDK7 substrate specificity by MAT1 and TFIIH.
    Yankulov KY; Bentley DL
    EMBO J; 1997 Apr; 16(7):1638-46. PubMed ID: 9130709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino terminus of Cdk2 binds p21.
    Moskowitz NK; Borao FJ; Dardashti O; Cohen HD; Germino FJ
    Oncol Res; 1996; 8(9):343-52. PubMed ID: 8979268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH.
    Rossignol M; Kolb-Cheynel I; Egly JM
    EMBO J; 1997 Apr; 16(7):1628-37. PubMed ID: 9130708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.